Eccentric? Default? The eu and AstraZeneta's vaccine supply problems remain unresolved

BEIJING, Jan. 29 (Xinhua) -- Britain's AstraZenecom Inc. has announced that it will significantly reduce its first-quarter vaccine supply to the European Union, drawing strong criticism from the European Union.
crisis meeting between the two sides on the 27th was also fruitless.
vaccine is expected to be approved by the European Medicines Agency on the 29th.
sudden reduction in vaccine supplies, the European Union "big fire" since AstraZeneca announced on January 22nd that it would significantly reduce the supply of vaccines to the European Union, the company's chief executive Suboko, in the European Union has become a target.
, the european union, said it would only supply 31m doses of the vaccine to the EU in the first quarter of this year, instead of the 80m it had previously said.
EU politicians were "very angry" about it.
, an EU lawmaker and health expert, suggested that if AstraZenecom failed to provide more vaccines as agreed and instead
treat EU citizens as second-class citizens", the EU must take steps, such as banning the export of Pfizer's new vaccine to the UK.
European Commission said it was considering requiring vaccine manufacturers to apply for export licenses in the future before supplying vaccines to countries outside the European Union.
for humanitarian goods, the European Union will issue and license.
is also known to produce new crown vaccines in the EU and ship them in part to the UK.
German Health Minister Peter Spang said the EU's aim in strengthening export reviews was to understand which vaccines were being exported so that contracts with suppliers were fairly enforced.
, despite a significant reduction in supply to the EU in the first quarter, AstraZeneta's supply to the UK will be on time and on time, with no reduction at all.
defended AstraZeneca after the European Union's backlash against the EU over the terms of the deal.
interview with several European media outlets, he said AstraZeneta had only indicated in its agreement with the EU in August 2020 that it would "do its utmost" to meet the agreed quantity of supplies, but did not state guaranteed supplies.
addition, the UK reached a vaccine supply agreement with AstraZeneta two months earlier than the EU, so AstraZene half a year earlier began producing vaccines for the UK.
the European Commission said the EU-AstraZeneca deal was only two weeks later than the UK's, and that the EU had pre-paid 336 million euros for vaccine production to get 300 million doses.
, the EUROPEAN health commissioner, said Mr Suboko's comments were neither true nor acceptable.
she said the EU-AstraZeneta agreement had a clear quarterly supply schedule, and that the agreement included a "best effort" clause because the vaccine had not been developed at the time and the agreed quantity would have to be supplied once the vaccine had been approved.
wants AstraZeneta to agree to a public agreement to boost transparency.
also stressed that AstraZeneta has moral, social and contractual responsibilities, "we are in a pandemic, losing our lives every day."
focus of the two sides" obsession is the EU's right to access vaccines produced by AstraZeneta.
AstraZeneta has a factory in Belgium and another in the European Union to produce the new crown vaccine.
said the decline in supply to the EU was due to production difficulties at its plant in Belgium.
But the European Commission pointed out that the agreement stipulated that AstraZeneca would produce and supply EU vaccines not only at the two plants, but also at two plants in the UK, and that AstraZeneca's UK plant had breached the agreement by producing vaccines only for the UK.
crisis meeting between the EUROPEAN Union and AstraZeneta on January 27th, when there was a huge gap between vaccination targets and reality.
participants expressed the view that the discussions between the two sides had been constructive, the meeting had not been fruitful.
don't want a dispute with AstraZeneta, we want a vaccine, we want a solution with the company," he said.
" European Medicines Agency is expected to approve the AstraZeneta vaccine on January 29.
the European Union has signed a total of more than 2.3 billion doses of vaccine supply agreements with six new crown vaccine manufacturers.
, 8.4 million of the EU's 450 million people have been vaccinated in one or two doses.
at the current rate, it would take more than two years for all EU residents willing to get two doses of the vaccine.
target for EU countries is to vaccinate 70 per cent of the population by the end of the summer.